Identification of the breast cancer susceptibility gene BRCA2
Richard Wooster(Institute of Cancer Research), Graham R. Bignell(Institute of Cancer Research), Jonathan Lancaster(National Institutes of Health), Sally Swift(Balfour Beatty (United Kingdom)), Sheila Seal(Institute of Cancer Research), Jonathan Mangion(Institute of Cancer Research), Nadine Collins(Institute of Cancer Research), Simon G. Gregory(Wellcome Sanger Institute), Curtis Gumbs(Duke Medical Center), Gos Micklem(Wellcome Sanger Institute), Rita Barfoot(Balfour Beatty (United Kingdom)), Rifat Hamoudi(Institute of Cancer Research), Sandeep Patel(Balfour Beatty (United Kingdom)), Catherine Rices(Wellcome Sanger Institute), Patrick J. Biggs(Balfour Beatty (United Kingdom)), Yasmin Hashim(Balfour Beatty (United Kingdom)), Amanda Smith(Balfour Beatty (United Kingdom)), Frances Connor(Balfour Beatty (United Kingdom)), Aðalgeir Arason, Jūlı́us Guðmundsson, D. Ficenec, David P. Kelsell, Deborah Ford(Balfour Beatty (United Kingdom)), Patricia N. Tonin(McGill University), D. Timothy Bishop(University of Leeds), Nigel K. Spurr, Bruce A.J. Ponder(Addenbrooke's Hospital), Rosalind A. Eeles(Balfour Beatty (United Kingdom)), Julian Peto(Balfour Beatty (United Kingdom)), Peter Devilee(Leiden University), Cees J. Cornelisse(Leiden University), Henry T. Lynch(Creighton University), Steven A. Narod, Gilbert Lenoir(Centre International de Recherche sur le Cancer), V Egilsson, Rosa Bjork Barkadottir, Douglas F. Easton(University of Cambridge), David Bentley(Wellcome Sanger Institute), P. Andrew Futreal(Duke Medical Center), Alan Ashworth(Institute of Cancer Research), Michael R. Stratton(Balfour Beatty (United Kingdom))
Cited by 3,651
Abstract
Related Papers
No related papers found
Powered by citation graph analysis